Stock Updates Stock Updates

Today’s Top Gainers in the Market Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) from Healthcare

Today’s top gainers include the company Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) which is in the industry Biotechnology, gaining 2.00% today. In the last week its performance is 7.13%, and 5.88% for the past quarter. Currently, Vertex Pharmaceuticals Incorporated, VRTX has a target price of 109, so today’s gain of 2.00% is a significant step towards its target price. The GAP today is therefore -0.41%.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), has a market cap of 21276.95, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 97.10%.

At the current price of 87.74, it has a dividend yield of *TBA, and its target price is 109. This is with a profit margin of -30.90%, and total debt/equity of 0.86. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has a P/E of *TBA, as well as a forward P/E of 26.4.

With a current EPS of -1.65, and a forecasted EPS growth for next year at 202.73%,Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has had a EPS growth for the past five years at 9.30%. For the next five years EPS growth is projected to be 51.20%.

Performance for the year is -33.16%. Since its IPO date on 7/24/1991, the total performance to date is -30.27%.

Volume today for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), is 1292692, while its average volume is 1923.55. Whilst the total gain today was 2.00%, it did have a day high of -9.07%.

Volatility for this week has been at 3.54%, and 3.45% for the month. The 52-week low for Vertex Pharmaceuticals Incorporated, VRTX has been 15.60%, while the 52-week-high has reached -38.84%.

Looking at its return of investments, which is -28.20%, and its return on assets is -16.30%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has an operating margin of -23.90%. With a sales growth of 187.40% quarter over quarter. Bearing in mind that Vertex Pharmaceuticals Incorporated, VRTX is in the sector Healthcare, its long-term debt/equity is 0.69, and has a current ratio of 2.5 and 2.4 for quick ratio.

So what is the value of Vertex Pharmaceuticals Incorporated? Well its PEG is *TBA, and the P/S is 16.47, along with a P/B of 22.33. Meanwhile it has a p/cash of 20.75.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment